PANDEMIC NOT PRE-PLANNED?........... THEN EXPLAIN THIS !!

WHAT HAVE WE HERE? On Nov. 15th 2019 nearly 20 positions were advertised for Public Health Advisors for a QUARANTINE PROGRAM by the CDC throughout the U.S. 

QUITE A PRESCIENT MOVE. As though they knew something was coming - something big, like a pandemic.


..

Pandemic a planned “scamdemic”?




We have learned in the past that False Flag events can leave a trail.  What sort of trail?  False Flag events require people. A “people trail”.
We’ve  all seen “crises actors”.  Some we have seen at multiple events.  These people are sourced from a variety of places.  One method to recruit people is through advertising.  Want ads/ Craig’slist, etc. The simplest  would be advertising on your website.
But we are not talking about crises  actors today.  We are talking about real educated  professionals. Actual scientist..
Who they are does not matter.  What matters,  is the time, position, location, skills required, job details and how long the job is for.  We also need to keep in mind as to why these people were hired.
Conveniently, they were hired right before the covid-19 outbreak.
The following can be found on the CDC  website.   It can be found under jobs.
Be sure to take the time to read all of it.
This was posted on 11_15/2019


Job ID HHS-CDC-D3-20-10640010 Date posted 11/15/2019 Location Dallas, Texas, El Paso, Texas, Houston, Texas, Seattle, Washington, Anchorage, Alaska, Los Angeles, California, San Diego, California, San Francisco, California, Miami, Florida, Atlanta, Georgia, Honolulu, Hawaii, Chicago, Illinois, Boston, Massachusetts, Detroit, Michigan, Minneapolis, Minnesota, Newark, New Jersey, New York, New York, Philadelphia, Pennsylvania, San Juan
Department: Department of Health And Human Services
Agency: Centers for Disease Control and Prevention
Job Announcement Number: HHS-CDC-D3-20-10640010
SALARY RANGE: $51440.0 to $93077.0/Per Year
OPEN PERIOD: 2019-11-15 to 2020-05-15
SERIES & GRADE: GS–9/11AGENCY MARKETING STATEMENT:
The Centers for Disease Control and Prevention (CDC) is the agency Americans trust with their lives. As a global leader in public health, CDC is the nation’s premier health promotion, prevention, and preparedness agency. Whether we are protecting the American people from public health threats, researching emerging diseases, or mobilizing public health programs with our domestic and international partners, we rely on our employees to make a real difference in the health and well-being of people here and around the world. This position is located in the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Emerging & Zoonotic Infectious Diseases (NCEZID), Division of Global Migration and Quarantine (DGMQ), Quarantine and Border Health Services Branch (QBHS) within various locations. Salary may be adjusted to include a Cost of Living Allowance (COLA) of 10.64% for Honolulu, Hawaii.
Salary may be adjusted to include a Cost of Living Allowance (COLA) of 3.27% for Anchorage, Alaska Salary may be adjusted to include a Cost of Living Allowance (COLA) of 3.29% for San Juan, Puerto Rico Term appointments may be shortened or extended up to a maximum of four years based on the needs of the agency without further competition. Subsequent employment for CDC positions must be through the appropriate competitive process or special employment program hiring authorities. CDC is an Equal Opportunity Employer.JOB SUMMARY:
Serves as a project representative for a program responsible for preventing the importation and spread of communicable diseases.DUTIES:
[
“Assist in planning and implementing a program for preventing the importation of communicable diseases from abroad and spread of these diseases domestically.”, “Monitor disease trends and consults with senior leaders to ensure that appropriate measures are taken to prevent the introduction/spread of communicable diseases by travelers, etiologic agents or vectors.”, “Provide technical assistance, consultation and guidance to national, state and/or local agencies; health organizations; federal, state and local law enforcement agencies; airport and seaport activities; hospital networks, and other private entities.”, “Ensure appropriate communication networks, planning documents and emergency response protocols are in place, tested and regularly updated.”, “Develop and present training to various governmental agencies and local partners on emergency response protocols, communicable diseases and quarantine activities.” ]REQUIREMENTS:
US Citizenship is required. Background Investigation is required. E-Verify: If you are selected for this position, the documentation that you present for purposes of completing the Department of Homeland Security (DHS) Form I-9 will be verified through the DHS “E-Verify” System. Federal law requires DHS to use the E-Verify System to verify employment eligibility of all new hires, and as a condition of continued employment obligates the new hire to take affirmative steps to resolve any discrepancies identified by the system. The U.S. Department of Health and Human Services is an E-Verify Participant. Direct Deposit: All Federal employees are required to have Federal salary payments made by direct deposit to a financial institution of their choosing. All qualification requirements must be met by the closing date of the announcement. One-year probationary period may be required. Travel, transportation, and moving expenses will be paid: Maybe Bargaining Unit Position: No Drug Screening Required: No Recruitment Incentive authorized: No Annual Leave for non-federal service authorized: No Research position: No Promotion potential: Yes, this position has promotion potential to GS-12. Promotion to the next grade level is at management’s discretion and is based on your meeting qualifications and time-in-grade requirements, demonstrated ability to perform the higher level duties, the continuing need for the higher level duties, and administrative approval. Promotion to the next grade level is not guaranteed and no promise of promotion is implied. Supervisory position: No Mobility Agreement Required: Yes Immunization required: YesQUALIFICATIONS REQUIRED:
Minimum Qualifications: GS-9
Applicants must have at least one year of specialized experience at or equivalent to the GS-7 in the Federal service as defined in the next paragraph. Specialized experience is experience which is directly related to the position which has equipped the applicant with the particular knowledge, skills and abilities (KSAs) to successfully perform the duties of the position to include experience assisting with providing advice and evaluating the effectiveness of public health programs, policies and activities. OR Have a master’s or equivalent graduate degree or 2 full years of progressively higher level graduate education leading to such a degree or LL.B. or J.D., if related. OR Have a combination of experience and education that meets 100% of the qualification requirements for this position. Minimum Qualifications: GS-11 Applicants must have one year of specialized experience at or equivalent to the GS-09 grade level of in the Federal service as defined in the next paragraph. Specialized experience is experience which is directly related to the position which has equipped the applicant with the particular knowledge, skills and abilities (KSAs) to successfully perform the duties of the position to include experience in planning, coordinating, developing and/or evaluating and implementing public health programs, policies, and activities. OR Have 3 years of progressively higher level graduate education leading to a Ph.D. or equivalent doctoral degree in public health or other field of study with course work directly related to the work of the position to be filled. OR Have a combination of specialized experience and graduate level education that meets 100% of the qualification requirements for this position.
HOW YOU WILL BE EVALUATED:
Once the application process is complete, a review of the resume and supporting documentation will be made and compared against your responses to the assessment questionnaire to determine if you are qualified for this job. If, after reviewing your resume and/or supporting documentation, a determination is made that you have inflated your qualifications and/or experience, you may lose consideration for this position. Please follow all instructions carefully. Errors or omissions may affect your eligibility. Category rating procedures will be used to rate and rank candidates. The category assignment is a measure of the degree to which your background matches the competencies required for this position. Qualified candidates will be ranked into one of three categories: Best Qualified, Well Qualified or Qualified. The Category Rating Process does not add veterans’ preference points but protects the rights of veterans by placing them ahead of non-preference eligibles within each category. Preference eligibles who meet the minimum qualification requirements and who have a compensable service-connected disability of at least 10 percent must be listed in the highest quality category (except in the case of scientific or professional positions at the GS-9 level or higher). Your qualifications will be evaluated on the following competencies (knowledge, skills, abilities and other characteristics).
Collaboration / PartneringContinuous DevelopmentCustomer ServiceData SynthesisNetworking and Partnership Development (2)Oral CommunicationProblem SolvingProgram AssessmentProgram Planning and DevelopmentPublic Health Information DisseminationPublic Health KnowledgeWritten Communication
BENEFITS:
OTHER INFORMATION:
Additional selections may be made within the same geographical location CDC-wide. The utilization of shared certificates within multiple Centers of the Center of Disease Control and Prevention may be used from this vacancy announcement for specialties to include but not limited to: Applied Epidemiology, Behavioral Epidemiology, Chronic Diseases, Emergency Preparedness and Response, Emerging Infectious Diseases, Environmental Health, HIV/AIDS, Immunization, Infectious Diseases (e.g. Viral, Parasitic, etc.), Influenza, Malaria, Non-communicable Diseases, Outbreak Investigations, Sexually Transmitted Diseases (STDs), Surveillance, Tropical Medicine, Tuberculosis (TB), Viral Hepatitis, and/or Zoonotic Diseases. If you are a veteran with preference eligibility and you are claiming 5-points veterans’ preference, you must submit a copy of your DD-214 or other proof of eligibility. If you are claiming 10-point veterans’ preference, you must also submit an SF-15, “Application for 10-Point Veterans’ Preference” plus the proof required by that form. For more information on veterans’ preference see http://www.fedshirevets.gov/job/vetpref/index.aspx. Males born after December 31, 1959 must be registered or exempt from Selective Service (see http://www.sss.gov). For information on “People with Disabilities” please see http://opm.gov/disability/PeopleWithDisabilities.asp
and https://www.opm.gov/policy-data-oversight/disability-employment/getting-a-job/sampleschedaletters.pdf. Interagency Career Transition Assistance Program (ICTAP)/ Career Transition Assistance Plan (CTAP): For information on how to apply as an ICTAP eligible see http://opm.gov/rif/employee_guides/career_transition.asp#ictap. To be well-qualified and exercise selection priority for this vacancy, displaced Federal employees must be rated at 85.0 or above on the rating criteria for this position. To view the questionnaire, click on the following link: https://apply.usastaffing.gov/ViewQuestionnaire/10640010 If you are unable to apply online or need to fax a document(s), view the following link for information regarding an Alternate Application.
HOW TO APPLY:
To apply for this position, you must complete the online application and submit the documentation specified in the Required Documents section. Special Notes – This announcement is being used to create an inventory of applicants for Public Health Advisor (Quarantine Program) positions and will be used to fill immediate and future needs. Applicants are encouraged to apply early in order to maximize their employment opportunities. Your application will remain in the inventory of tentatively qualified applicants. Applicants that are among the best qualified will be referred to the selecting official for consideration as requests to fill vacancies are processed by the Human Resources Office. The first cut-off date for you to be referred will be December 2, 2019. Thereafter, additional referral lists will be generated throughout the open period as vacancies occur. If further evaluation or interviews are required, you will be contacted. This is an open continuous announcement. Qualified applicants will be considered as job opportunities occur and may or may not receive further notification regarding the status of their application. A complete application package must be submitted by 11:59 PM (EST) on05/15/2020 of this announcement to receive consideration. To begin, click Apply to access the online application. You will need to be logged into your USAJOBS account to apply. If you do not have a USAJOBS account, you will need to create one before beginning the application. Follow the prompts to select your résumé and/or other supporting documents to be included with your application package. You will have the opportunity to upload additional documents to include in your application before it is submitted. Your uploaded documents may take several hours to clear the virus scan process. After acknowledging you have reviewed your application package, complete the Include Personal Information section as you deem appropriate and click to continue with the application process. You will be taken to the online application which you must complete in order to apply for the position. Complete the online application, verify the required documentation is included with your application package, and submit the application. To verify the status of your application, log into your USAJOBS account (https://my.usajobs.gov/Account/Login), all of your applications will appear on the Welcome screen. The Application Status will appear along with the date your application was last updated. For information on what each Application Status means, visit: https://www.usajobs.gov/Help/how-to/application/status/. If you cannot apply online: You are encouraged to apply online. If you are unable to apply online, please use the Alternate Application link listed in the Additional Information section of this vacancy announcement. Applicants are strongly encouraged to apply online if at all possible. Applying online, through your USAJOBS account, will expedite the application process and allow you to check your application. If you utilize the Alternate Application method, your USAJOBS account will not display this application and you will not receive status updates.
REQUIRED DOCUMENTS:
To apply for this position, you must submit a complete Application Package which includes: Your résumé showing work schedule, hours worked per week, dates of employment and duties performed. Other supporting documents: Cover Letter, optional Veterans Preference Documentation, if applicable Transcripts (if applicable)* Schedule A Eligibility Letter, if you are applying as a Schedule A candidate Interagency Career Transition Assistance Program / Career Transition Assistance Program documentation, if applicable (e.g., Certification of Expected Separation, Reduction-In-Force Separation Notice, or Notice of Proposed Removal; SF-50 that documents the RIF separation action; and most recent performance appraisal). *Note: You may submit an unofficial transcript or a list of college courses completed indicating course titles, credit hours, and grades received. An official transcript from an accredited educational institution is required if you are selected for the position. Failure to submit any of the above mentioned required documents will result in loss of consideration due to an incomplete application package. It is your responsibility to ensure all required documents have been submitted. OTHER JOB INFORMATION:
Subject to permanent reassignment to another CDC Quarantine Station or duty station as the needs of the service warrant. Subject to temporary assignment at any location in the United States and its territories or possessions, in foreign countries, or at sea. Selectee will be required to sign a Geographic Mobility Agreement. These positions are subject to shift work, weekend work, irregular work schedule and evening hours. On call 24 hours a day, 7 days a week, independent of shift work assignments. The incumbents will be required to wear a uniform. The incumbent must be able to qualify for unrestricted access to secure areas at U.S ports. The incumbent must be able to qualify for a secret security clearance. The incumbent must be able to obtain an official U.S. passport. The incumbent must have a valid State government-issued driver’s license. The incumbent is required to be current in his/her immunizations per ACIP guidelines. Must undergo baseline and periodic health screening procedures such as respiratory fit testing and PPD tests for tuberculosis exposure. May be required to wear an N-95 respirator. The incumbent must be physically fit enough to work long hours and frequently travel on foot to remote gate areas in a short period of time. The incumbent must be required to provide basic quarantine station support, including purchasing, property inventory, document processing, timekeeping, and answering inquiries, etc. For Résumé and Application Tips visit: https://help.usajobs.gov/index.php/Tips.
WHAT TO EXPECT NEXT:
Once the online questionnaire is received you will receive an acknowledgement email that your submission was successful. The most highly qualified candidates will be referred to the hiring manager for further consideration and possible interview. We expect to make a selection within 45 days of the closing date of this announcement. You will receive notice via email once this process is completed (generally 4-6 weeks).
AGENCY CONTACT INFO:
CDC HELPDESK
1600 Clifton Road NE
Atlanta GA US 30333
Telephone: (770) 488-1725
Email: HRCS@CDC.GOV
I’m  not saying the pandemics was a False Flag event.  That’s  for you to decide.
The duration of employment fits the timeline of the Covid-19 outbreak.  It also fits the timeline I  pointed out in my post “Deception of the sleazoid swamp donkey. “
Taking all the factual information I have gathered. Add this to it. Add the rest of the relevant  post and comments from authors and subscribers here on FOTM. Then ask yourself two things. Why? And what are you going to do about it?
Respectfully
Deplorable Patroit
Democrat leadership are responsible for all jobs lost,all business  closures along with every hardship that is the result of ccovid-19 pandemic.

Source

..

PANDEMIC NOT PRE-PLANNED?........... THEN EXPLAIN THIS !!

WHAT HAVE WE HERE? On Nov. 15th 2019 nearly 20 positions were advertised for Public Health Advisors for a QUARANTINE PROGRAM by the CDC throughout the U.S. 

QUITE A PRESCIENT MOVE. As though they knew something was coming - something big, like a pandemic.


..

Pandemic a planned “scamdemic”?




We have learned in the past that False Flag events can leave a trail.  What sort of trail?  False Flag events require people. A “people trail”.
We’ve  all seen “crises actors”.  Some we have seen at multiple events.  These people are sourced from a variety of places.  One method to recruit people is through advertising.  Want ads/ Craig’slist, etc. The simplest  would be advertising on your website.
But we are not talking about crises  actors today.  We are talking about real educated  professionals. Actual scientist..
Who they are does not matter.  What matters,  is the time, position, location, skills required, job details and how long the job is for.  We also need to keep in mind as to why these people were hired.
Conveniently, they were hired right before the covid-19 outbreak.
The following can be found on the CDC  website.   It can be found under jobs.
Be sure to take the time to read all of it.
This was posted on 11_15/2019


Job ID HHS-CDC-D3-20-10640010 Date posted 11/15/2019 Location Dallas, Texas, El Paso, Texas, Houston, Texas, Seattle, Washington, Anchorage, Alaska, Los Angeles, California, San Diego, California, San Francisco, California, Miami, Florida, Atlanta, Georgia, Honolulu, Hawaii, Chicago, Illinois, Boston, Massachusetts, Detroit, Michigan, Minneapolis, Minnesota, Newark, New Jersey, New York, New York, Philadelphia, Pennsylvania, San Juan
Department: Department of Health And Human Services
Agency: Centers for Disease Control and Prevention
Job Announcement Number: HHS-CDC-D3-20-10640010
SALARY RANGE: $51440.0 to $93077.0/Per Year
OPEN PERIOD: 2019-11-15 to 2020-05-15
SERIES & GRADE: GS–9/11AGENCY MARKETING STATEMENT:
The Centers for Disease Control and Prevention (CDC) is the agency Americans trust with their lives. As a global leader in public health, CDC is the nation’s premier health promotion, prevention, and preparedness agency. Whether we are protecting the American people from public health threats, researching emerging diseases, or mobilizing public health programs with our domestic and international partners, we rely on our employees to make a real difference in the health and well-being of people here and around the world. This position is located in the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Emerging & Zoonotic Infectious Diseases (NCEZID), Division of Global Migration and Quarantine (DGMQ), Quarantine and Border Health Services Branch (QBHS) within various locations. Salary may be adjusted to include a Cost of Living Allowance (COLA) of 10.64% for Honolulu, Hawaii.
Salary may be adjusted to include a Cost of Living Allowance (COLA) of 3.27% for Anchorage, Alaska Salary may be adjusted to include a Cost of Living Allowance (COLA) of 3.29% for San Juan, Puerto Rico Term appointments may be shortened or extended up to a maximum of four years based on the needs of the agency without further competition. Subsequent employment for CDC positions must be through the appropriate competitive process or special employment program hiring authorities. CDC is an Equal Opportunity Employer.JOB SUMMARY:
Serves as a project representative for a program responsible for preventing the importation and spread of communicable diseases.DUTIES:
[
“Assist in planning and implementing a program for preventing the importation of communicable diseases from abroad and spread of these diseases domestically.”, “Monitor disease trends and consults with senior leaders to ensure that appropriate measures are taken to prevent the introduction/spread of communicable diseases by travelers, etiologic agents or vectors.”, “Provide technical assistance, consultation and guidance to national, state and/or local agencies; health organizations; federal, state and local law enforcement agencies; airport and seaport activities; hospital networks, and other private entities.”, “Ensure appropriate communication networks, planning documents and emergency response protocols are in place, tested and regularly updated.”, “Develop and present training to various governmental agencies and local partners on emergency response protocols, communicable diseases and quarantine activities.” ]REQUIREMENTS:
US Citizenship is required. Background Investigation is required. E-Verify: If you are selected for this position, the documentation that you present for purposes of completing the Department of Homeland Security (DHS) Form I-9 will be verified through the DHS “E-Verify” System. Federal law requires DHS to use the E-Verify System to verify employment eligibility of all new hires, and as a condition of continued employment obligates the new hire to take affirmative steps to resolve any discrepancies identified by the system. The U.S. Department of Health and Human Services is an E-Verify Participant. Direct Deposit: All Federal employees are required to have Federal salary payments made by direct deposit to a financial institution of their choosing. All qualification requirements must be met by the closing date of the announcement. One-year probationary period may be required. Travel, transportation, and moving expenses will be paid: Maybe Bargaining Unit Position: No Drug Screening Required: No Recruitment Incentive authorized: No Annual Leave for non-federal service authorized: No Research position: No Promotion potential: Yes, this position has promotion potential to GS-12. Promotion to the next grade level is at management’s discretion and is based on your meeting qualifications and time-in-grade requirements, demonstrated ability to perform the higher level duties, the continuing need for the higher level duties, and administrative approval. Promotion to the next grade level is not guaranteed and no promise of promotion is implied. Supervisory position: No Mobility Agreement Required: Yes Immunization required: YesQUALIFICATIONS REQUIRED:
Minimum Qualifications: GS-9
Applicants must have at least one year of specialized experience at or equivalent to the GS-7 in the Federal service as defined in the next paragraph. Specialized experience is experience which is directly related to the position which has equipped the applicant with the particular knowledge, skills and abilities (KSAs) to successfully perform the duties of the position to include experience assisting with providing advice and evaluating the effectiveness of public health programs, policies and activities. OR Have a master’s or equivalent graduate degree or 2 full years of progressively higher level graduate education leading to such a degree or LL.B. or J.D., if related. OR Have a combination of experience and education that meets 100% of the qualification requirements for this position. Minimum Qualifications: GS-11 Applicants must have one year of specialized experience at or equivalent to the GS-09 grade level of in the Federal service as defined in the next paragraph. Specialized experience is experience which is directly related to the position which has equipped the applicant with the particular knowledge, skills and abilities (KSAs) to successfully perform the duties of the position to include experience in planning, coordinating, developing and/or evaluating and implementing public health programs, policies, and activities. OR Have 3 years of progressively higher level graduate education leading to a Ph.D. or equivalent doctoral degree in public health or other field of study with course work directly related to the work of the position to be filled. OR Have a combination of specialized experience and graduate level education that meets 100% of the qualification requirements for this position.
HOW YOU WILL BE EVALUATED:
Once the application process is complete, a review of the resume and supporting documentation will be made and compared against your responses to the assessment questionnaire to determine if you are qualified for this job. If, after reviewing your resume and/or supporting documentation, a determination is made that you have inflated your qualifications and/or experience, you may lose consideration for this position. Please follow all instructions carefully. Errors or omissions may affect your eligibility. Category rating procedures will be used to rate and rank candidates. The category assignment is a measure of the degree to which your background matches the competencies required for this position. Qualified candidates will be ranked into one of three categories: Best Qualified, Well Qualified or Qualified. The Category Rating Process does not add veterans’ preference points but protects the rights of veterans by placing them ahead of non-preference eligibles within each category. Preference eligibles who meet the minimum qualification requirements and who have a compensable service-connected disability of at least 10 percent must be listed in the highest quality category (except in the case of scientific or professional positions at the GS-9 level or higher). Your qualifications will be evaluated on the following competencies (knowledge, skills, abilities and other characteristics).
Collaboration / PartneringContinuous DevelopmentCustomer ServiceData SynthesisNetworking and Partnership Development (2)Oral CommunicationProblem SolvingProgram AssessmentProgram Planning and DevelopmentPublic Health Information DisseminationPublic Health KnowledgeWritten Communication
BENEFITS:
OTHER INFORMATION:
Additional selections may be made within the same geographical location CDC-wide. The utilization of shared certificates within multiple Centers of the Center of Disease Control and Prevention may be used from this vacancy announcement for specialties to include but not limited to: Applied Epidemiology, Behavioral Epidemiology, Chronic Diseases, Emergency Preparedness and Response, Emerging Infectious Diseases, Environmental Health, HIV/AIDS, Immunization, Infectious Diseases (e.g. Viral, Parasitic, etc.), Influenza, Malaria, Non-communicable Diseases, Outbreak Investigations, Sexually Transmitted Diseases (STDs), Surveillance, Tropical Medicine, Tuberculosis (TB), Viral Hepatitis, and/or Zoonotic Diseases. If you are a veteran with preference eligibility and you are claiming 5-points veterans’ preference, you must submit a copy of your DD-214 or other proof of eligibility. If you are claiming 10-point veterans’ preference, you must also submit an SF-15, “Application for 10-Point Veterans’ Preference” plus the proof required by that form. For more information on veterans’ preference see http://www.fedshirevets.gov/job/vetpref/index.aspx. Males born after December 31, 1959 must be registered or exempt from Selective Service (see http://www.sss.gov). For information on “People with Disabilities” please see http://opm.gov/disability/PeopleWithDisabilities.asp
and https://www.opm.gov/policy-data-oversight/disability-employment/getting-a-job/sampleschedaletters.pdf. Interagency Career Transition Assistance Program (ICTAP)/ Career Transition Assistance Plan (CTAP): For information on how to apply as an ICTAP eligible see http://opm.gov/rif/employee_guides/career_transition.asp#ictap. To be well-qualified and exercise selection priority for this vacancy, displaced Federal employees must be rated at 85.0 or above on the rating criteria for this position. To view the questionnaire, click on the following link: https://apply.usastaffing.gov/ViewQuestionnaire/10640010 If you are unable to apply online or need to fax a document(s), view the following link for information regarding an Alternate Application.
HOW TO APPLY:
To apply for this position, you must complete the online application and submit the documentation specified in the Required Documents section. Special Notes – This announcement is being used to create an inventory of applicants for Public Health Advisor (Quarantine Program) positions and will be used to fill immediate and future needs. Applicants are encouraged to apply early in order to maximize their employment opportunities. Your application will remain in the inventory of tentatively qualified applicants. Applicants that are among the best qualified will be referred to the selecting official for consideration as requests to fill vacancies are processed by the Human Resources Office. The first cut-off date for you to be referred will be December 2, 2019. Thereafter, additional referral lists will be generated throughout the open period as vacancies occur. If further evaluation or interviews are required, you will be contacted. This is an open continuous announcement. Qualified applicants will be considered as job opportunities occur and may or may not receive further notification regarding the status of their application. A complete application package must be submitted by 11:59 PM (EST) on05/15/2020 of this announcement to receive consideration. To begin, click Apply to access the online application. You will need to be logged into your USAJOBS account to apply. If you do not have a USAJOBS account, you will need to create one before beginning the application. Follow the prompts to select your résumé and/or other supporting documents to be included with your application package. You will have the opportunity to upload additional documents to include in your application before it is submitted. Your uploaded documents may take several hours to clear the virus scan process. After acknowledging you have reviewed your application package, complete the Include Personal Information section as you deem appropriate and click to continue with the application process. You will be taken to the online application which you must complete in order to apply for the position. Complete the online application, verify the required documentation is included with your application package, and submit the application. To verify the status of your application, log into your USAJOBS account (https://my.usajobs.gov/Account/Login), all of your applications will appear on the Welcome screen. The Application Status will appear along with the date your application was last updated. For information on what each Application Status means, visit: https://www.usajobs.gov/Help/how-to/application/status/. If you cannot apply online: You are encouraged to apply online. If you are unable to apply online, please use the Alternate Application link listed in the Additional Information section of this vacancy announcement. Applicants are strongly encouraged to apply online if at all possible. Applying online, through your USAJOBS account, will expedite the application process and allow you to check your application. If you utilize the Alternate Application method, your USAJOBS account will not display this application and you will not receive status updates.
REQUIRED DOCUMENTS:
To apply for this position, you must submit a complete Application Package which includes: Your résumé showing work schedule, hours worked per week, dates of employment and duties performed. Other supporting documents: Cover Letter, optional Veterans Preference Documentation, if applicable Transcripts (if applicable)* Schedule A Eligibility Letter, if you are applying as a Schedule A candidate Interagency Career Transition Assistance Program / Career Transition Assistance Program documentation, if applicable (e.g., Certification of Expected Separation, Reduction-In-Force Separation Notice, or Notice of Proposed Removal; SF-50 that documents the RIF separation action; and most recent performance appraisal). *Note: You may submit an unofficial transcript or a list of college courses completed indicating course titles, credit hours, and grades received. An official transcript from an accredited educational institution is required if you are selected for the position. Failure to submit any of the above mentioned required documents will result in loss of consideration due to an incomplete application package. It is your responsibility to ensure all required documents have been submitted. OTHER JOB INFORMATION:
Subject to permanent reassignment to another CDC Quarantine Station or duty station as the needs of the service warrant. Subject to temporary assignment at any location in the United States and its territories or possessions, in foreign countries, or at sea. Selectee will be required to sign a Geographic Mobility Agreement. These positions are subject to shift work, weekend work, irregular work schedule and evening hours. On call 24 hours a day, 7 days a week, independent of shift work assignments. The incumbents will be required to wear a uniform. The incumbent must be able to qualify for unrestricted access to secure areas at U.S ports. The incumbent must be able to qualify for a secret security clearance. The incumbent must be able to obtain an official U.S. passport. The incumbent must have a valid State government-issued driver’s license. The incumbent is required to be current in his/her immunizations per ACIP guidelines. Must undergo baseline and periodic health screening procedures such as respiratory fit testing and PPD tests for tuberculosis exposure. May be required to wear an N-95 respirator. The incumbent must be physically fit enough to work long hours and frequently travel on foot to remote gate areas in a short period of time. The incumbent must be required to provide basic quarantine station support, including purchasing, property inventory, document processing, timekeeping, and answering inquiries, etc. For Résumé and Application Tips visit: https://help.usajobs.gov/index.php/Tips.
WHAT TO EXPECT NEXT:
Once the online questionnaire is received you will receive an acknowledgement email that your submission was successful. The most highly qualified candidates will be referred to the hiring manager for further consideration and possible interview. We expect to make a selection within 45 days of the closing date of this announcement. You will receive notice via email once this process is completed (generally 4-6 weeks).
AGENCY CONTACT INFO:
CDC HELPDESK
1600 Clifton Road NE
Atlanta GA US 30333
Telephone: (770) 488-1725
Email: HRCS@CDC.GOV
I’m  not saying the pandemics was a False Flag event.  That’s  for you to decide.
The duration of employment fits the timeline of the Covid-19 outbreak.  It also fits the timeline I  pointed out in my post “Deception of the sleazoid swamp donkey. “
Taking all the factual information I have gathered. Add this to it. Add the rest of the relevant  post and comments from authors and subscribers here on FOTM. Then ask yourself two things. Why? And what are you going to do about it?
Respectfully
Deplorable Patroit
Democrat leadership are responsible for all jobs lost,all business  closures along with every hardship that is the result of ccovid-19 pandemic.

Source

..

COVID VACCINE MAY BE UNAPPROVED


..

Regulators would consider releasing an unapproved coronavirus vaccine

May 8, 2020
Olivia Goldhill
By Olivia Goldhill
Science reporter

FROM OUR OBSESSION

Global Economic Disruptions

Globalization, automation, and inequality.
In April, Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAID), said a coronavirus vaccine was “on track” to be distributed to the public in 12 to 18 months.
Compared to typical vaccine timelines, that estimate looks laughable. The rotavirus vaccine was approved after 26 years of testing, offers Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia and co-creator of that vaccine. “Did it feel like a long time? No,” he says. “I thought we were going through the process as you should go through it.”
Even after a company submits evidence from years of clinical trials, it usually takes the US Food and Drug Administration (FDA) about a year to approve a vaccine. So to meet Fauci’s timeline, a vaccine would likely have to be released to the general public before it is formally approved.
The FDA’s approval process has already been circumvented in the rush to combat coronavirus. Both treatments and tests for Covid-19 have been granted emergency use authorization (EUA), which allow companies to distribute their products to patients based on the submission of limited validation data. And the FDA tells Quartz it would consider this authorization process for a coronavirus vaccine, too.
Offit, who is on the FDA vaccine advisory committee, is unequivocal: He does not expect a coronavirus vaccine to go through a traditional approval process before it’s widely used. But in order to balance safety with speed, an emergency-authorized vaccine will have to be deployed carefully. For guidance, researchers can look to another unapproved vaccine that was deployed in an emergency.

Emergency use

In 2014, as Ebola killed thousands of people across West Africa, an experimental vaccine was given to healthcare workers and their families in Liberia, Sierra Leone, and Guinea as part of phase two and three studies. In other words, the vaccine was being tested for efficacy as it was used in an emergency situation. On the basis of those studies, the vaccine was formally approved five years later, in 2019.
That strategy was considered a success. And some of the challenges faced in the Ebola trials’ execution could inform the deployment of an unapproved coronavirus vaccine.
Most of the Ebola vaccine studies were abandoned along the way: The epidemic died out before researchers could recruit enough participants. The one trial that did finish, in Guinea, used contact tracing among healthcare workers to identify people who were exposed, which allowed researchers to quickly recruit participants who were at high risk of infection. This allowed them to compare infection rates between those who got the vaccine versus placebo.
“It is not clear that we could use this strategy for Covid-19,” says Alex John London, director of the Center for Ethics and Policy at Carnegie Mellon University, since so many people with coronavirus are asymptomatic and spread it unknowingly. But several researchers believe a related strategy could work to test a coronavirus vaccine.
Stanley Plotkin, whose research contributed to the development of vaccines for rubella, rabies, and polio, says the FDA could allow a vaccine to be tested in the field among groups at high risk of exposure. Emergency use authorization could allow a vaccine to be distributed to healthcare workers, for example, and the use of vaccines within this population could be studied as part of a phase three trial.
This real-world testing could allow researchers to continue building up data as the vaccine is used. As evidence strengthens, the FDA could authorize the vaccine to be used on larger populations, until there’s eventually enough evidence for formal approval.

Unintended harms

Still, there are many differences between the response to the coronavirus crisis and the Ebola outbreak. Researchers already had evidence that the Ebola vaccine was protective in humans, says London, and there was considerable safety data from phase one studies. Ebola vaccines had been in development for decades, whereas scientists first saw SARS-CoV-2, the coronavirus that causes Covid-19, last year.
That’s why, before a coronavirus vaccine can be distributed to at-risk populations, it first has to go through safety trials—albeit, much faster than normal.
Most vaccine trials would start with testing on animals, but standard lab mice aren’t susceptible to coronavirus. So several Covid-19 studies have proceeded straight to human trials, occasionally running mice studies in parallel. The first coronavirus vaccine study to start human testing injected the vaccine into mice on the same day it began enrolling human subjects.
Boston biotech company Moderna, which created the first coronavirus vaccine to begin human testing, doesn’t even have full phase one safety results yet, but today the FDA granted approval to move ahead to a phase two efficacy trial. Moderna now aims to start a phase three trial this summer. “Everything as a company we’re able to do, we’ve tried to do at lightning speed while keeping safety in mind,” says Ray Jordan, head of corporate affairs at Moderna.
Meanwhile, Oxford University researchers in the UK have launched an unusually huge phase one safety trial with 1,000 participants. They plan to launch a combined phase two and phase three trial next month with 5,000 participants. The scientists say their vaccine could be available by September, as long as it gets emergency authorization from British regulators.
These accelerated safety trials will be critical to control the distribution of a vaccine that’s given emergency authorization. The FDA has already authorized the use of Covid-19 treatments, but “the tradeoffs are different when talking about someone who’s infected versus someone who’s never been infected,” says Holly Fernandez Lynch, a medical ethics professor at the University of Pennsylvania. “It’s one thing to give a dying patient an unapproved drug to try and save them, and very different to give an unapproved vaccine to a healthy person.”
History provides plenty of reasons to be wary. In 1955, a hastily-approved polio vaccine contained live polio virus, which killed 10 children and created 200 cases of paralysis. In 1976, a swine flu vaccine created 10 cases of Guillain-Barré syndrome per million people vaccinated, killing 25 people. And occasionally, vaccines can create a more intense form of the illness they’re intended to protect against: In 2017, a vaccine against dengue fever was suspended in the Philippines, after it was discovered that, in rare cases, it increased the risk of severe infection among those who hadn’t been previously infected.

Catch and release

But compared to the death toll of Covid-19, those risks may be acceptable to regulators.
The FDA will only issue an emergency use authorization if several statutory requirements are met, including an assessment “that the known and potential benefits of a product outweigh the known and potential risks,” FDA spokesperson Michael Felberbaum wrote in an email to Quartz. “In the case of investigational vaccines being developed for the prevention of Covid-19, this assessment will be made on a case by case basis depending on the characteristics of the product, the preclinical and human clinical study data on the product, and the totality of the available scientific evidence relevant to the product.”
Jordan says Moderna knows its vaccine could be released under EUA. “That’s a tool within the regulatory framework,” he says. “We expect the FDA to look at risk-benefit tradeoffs. We have confidence that the regulators are very aware of the urgency and risks.”
Even after a vaccine has been formally approved, it still carries risks. “There’s no such thing as something that’s objectively safe,” says Lynch. “I challenge you to find any FDA product that doesn’t have warnings on its label.” Instead, she says, regulators have to decide whether a vaccine is “safe enough.”
Now, “safe enough” is relative to the thousands of people dying from the virus every week. Given that trend, Offit says it makes sense to distribute a vaccine ahead of approval. “As long as people are aware they’re now taking a product that has not been tested in the typical way,” he says.
In the Ebola trial in Guinea, participants signed informed consent documents after the researchers explained the vaccine’s potential risks, benefits, or lack thereof. Any distribution of an unapproved coronavirus vaccine would have to include similar transparency.
Then, the only thing to do is wait and hope for the best. As the father of modern vaccination Maurice Hilleman, who created dozens of vaccines for viruses including measles, mumps, meningitis, pneumonia, and rubella, used to say, “I never breathe a sigh of relief until the first 3 million doses are out there.”

COVID VACCINE MAY BE UNAPPROVED


..

Regulators would consider releasing an unapproved coronavirus vaccine

May 8, 2020
By Olivia Goldhill
Science reporter

FROM OUR OBSESSION

Global Economic Disruptions

Globalization, automation, and inequality.
In April, Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAID), said a coronavirus vaccine was “on track” to be distributed to the public in 12 to 18 months.
Compared to typical vaccine timelines, that estimate looks laughable. The rotavirus vaccine was approved after 26 years of testing, offers Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia and co-creator of that vaccine. “Did it feel like a long time? No,” he says. “I thought we were going through the process as you should go through it.”
Even after a company submits evidence from years of clinical trials, it usually takes the US Food and Drug Administration (FDA) about a year to approve a vaccine. So to meet Fauci’s timeline, a vaccine would likely have to be released to the general public before it is formally approved.
The FDA’s approval process has already been circumvented in the rush to combat coronavirus. Both treatments and tests for Covid-19 have been granted emergency use authorization (EUA), which allow companies to distribute their products to patients based on the submission of limited validation data. And the FDA tells Quartz it would consider this authorization process for a coronavirus vaccine, too.
Offit, who is on the FDA vaccine advisory committee, is unequivocal: He does not expect a coronavirus vaccine to go through a traditional approval process before it’s widely used. But in order to balance safety with speed, an emergency-authorized vaccine will have to be deployed carefully. For guidance, researchers can look to another unapproved vaccine that was deployed in an emergency.

Emergency use

In 2014, as Ebola killed thousands of people across West Africa, an experimental vaccine was given to healthcare workers and their families in Liberia, Sierra Leone, and Guinea as part of phase two and three studies. In other words, the vaccine was being tested for efficacy as it was used in an emergency situation. On the basis of those studies, the vaccine was formally approved five years later, in 2019.
That strategy was considered a success. And some of the challenges faced in the Ebola trials’ execution could inform the deployment of an unapproved coronavirus vaccine.
Most of the Ebola vaccine studies were abandoned along the way: The epidemic died out before researchers could recruit enough participants. The one trial that did finish, in Guinea, used contact tracing among healthcare workers to identify people who were exposed, which allowed researchers to quickly recruit participants who were at high risk of infection. This allowed them to compare infection rates between those who got the vaccine versus placebo.
“It is not clear that we could use this strategy for Covid-19,” says Alex John London, director of the Center for Ethics and Policy at Carnegie Mellon University, since so many people with coronavirus are asymptomatic and spread it unknowingly. But several researchers believe a related strategy could work to test a coronavirus vaccine.
Stanley Plotkin, whose research contributed to the development of vaccines for rubella, rabies, and polio, says the FDA could allow a vaccine to be tested in the field among groups at high risk of exposure. Emergency use authorization could allow a vaccine to be distributed to healthcare workers, for example, and the use of vaccines within this population could be studied as part of a phase three trial.
This real-world testing could allow researchers to continue building up data as the vaccine is used. As evidence strengthens, the FDA could authorize the vaccine to be used on larger populations, until there’s eventually enough evidence for formal approval.

Unintended harms

Still, there are many differences between the response to the coronavirus crisis and the Ebola outbreak. Researchers already had evidence that the Ebola vaccine was protective in humans, says London, and there was considerable safety data from phase one studies. Ebola vaccines had been in development for decades, whereas scientists first saw SARS-CoV-2, the coronavirus that causes Covid-19, last year.
That’s why, before a coronavirus vaccine can be distributed to at-risk populations, it first has to go through safety trials—albeit, much faster than normal.
Most vaccine trials would start with testing on animals, but standard lab mice aren’t susceptible to coronavirus. So several Covid-19 studies have proceeded straight to human trials, occasionally running mice studies in parallel. The first coronavirus vaccine study to start human testing injected the vaccine into mice on the same day it began enrolling human subjects.
Boston biotech company Moderna, which created the first coronavirus vaccine to begin human testing, doesn’t even have full phase one safety results yet, but today the FDA granted approval to move ahead to a phase two efficacy trial. Moderna now aims to start a phase three trial this summer. “Everything as a company we’re able to do, we’ve tried to do at lightning speed while keeping safety in mind,” says Ray Jordan, head of corporate affairs at Moderna.
Meanwhile, Oxford University researchers in the UK have launched an unusually huge phase one safety trial with 1,000 participants. They plan to launch a combined phase two and phase three trial next month with 5,000 participants. The scientists say their vaccine could be available by September, as long as it gets emergency authorization from British regulators.
These accelerated safety trials will be critical to control the distribution of a vaccine that’s given emergency authorization. The FDA has already authorized the use of Covid-19 treatments, but “the tradeoffs are different when talking about someone who’s infected versus someone who’s never been infected,” says Holly Fernandez Lynch, a medical ethics professor at the University of Pennsylvania. “It’s one thing to give a dying patient an unapproved drug to try and save them, and very different to give an unapproved vaccine to a healthy person.”
History provides plenty of reasons to be wary. In 1955, a hastily-approved polio vaccine contained live polio virus, which killed 10 children and created 200 cases of paralysis. In 1976, a swine flu vaccine created 10 cases of Guillain-Barré syndrome per million people vaccinated, killing 25 people. And occasionally, vaccines can create a more intense form of the illness they’re intended to protect against: In 2017, a vaccine against dengue fever was suspended in the Philippines, after it was discovered that, in rare cases, it increased the risk of severe infection among those who hadn’t been previously infected.

Catch and release

But compared to the death toll of Covid-19, those risks may be acceptable to regulators.
The FDA will only issue an emergency use authorization if several statutory requirements are met, including an assessment “that the known and potential benefits of a product outweigh the known and potential risks,” FDA spokesperson Michael Felberbaum wrote in an email to Quartz. “In the case of investigational vaccines being developed for the prevention of Covid-19, this assessment will be made on a case by case basis depending on the characteristics of the product, the preclinical and human clinical study data on the product, and the totality of the available scientific evidence relevant to the product.”
Jordan says Moderna knows its vaccine could be released under EUA. “That’s a tool within the regulatory framework,” he says. “We expect the FDA to look at risk-benefit tradeoffs. We have confidence that the regulators are very aware of the urgency and risks.”
Even after a vaccine has been formally approved, it still carries risks. “There’s no such thing as something that’s objectively safe,” says Lynch. “I challenge you to find any FDA product that doesn’t have warnings on its label.” Instead, she says, regulators have to decide whether a vaccine is “safe enough.”
Now, “safe enough” is relative to the thousands of people dying from the virus every week. Given that trend, Offit says it makes sense to distribute a vaccine ahead of approval. “As long as people are aware they’re now taking a product that has not been tested in the typical way,” he says.
In the Ebola trial in Guinea, participants signed informed consent documents after the researchers explained the vaccine’s potential risks, benefits, or lack thereof. Any distribution of an unapproved coronavirus vaccine would have to include similar transparency.
Then, the only thing to do is wait and hope for the best. As the father of modern vaccination Maurice Hilleman, who created dozens of vaccines for viruses including measles, mumps, meningitis, pneumonia, and rubella, used to say, “I never breathe a sigh of relief until the first 3 million doses are out there.”